Invention Grant
- Patent Title: Adoptive immunotherapy for treating cancer
-
Application No.: US15536258Application Date: 2015-12-15
-
Publication No.: US10858626B2Publication Date: 2020-12-08
- Inventor: Marie-Agnes Doucey , Nicolas Guex , Isaac Crespo , Ioannis Xenarios
- Applicant: UNIVERSITÉ DE LAUSANNE
- Applicant Address: CH Lausanne
- Assignee: UNIVERSITÉ DE LAUSANNE
- Current Assignee: UNIVERSITÉ DE LAUSANNE
- Current Assignee Address: CH Lausanne
- Agency: Harness Dickey & Pierce P.L.C.
- Priority: EP14198399 20141217
- International Application: PCT/EP2015/079867 WO 20151215
- International Announcement: WO2016/096903 WO 20160623
- Main IPC: A61K31/00
- IPC: A61K31/00 ; C12N5/0783 ; A61K39/00 ; A61K31/444 ; A61K31/4709 ; A61K31/496 ; A61K31/502 ; A61K31/517 ; A61K31/5377 ; A61K45/06 ; A61K31/404 ; A61K31/44 ; A61K31/5025 ; A61K31/506 ; A61K31/4439 ; A61K31/47 ; A61K31/4365
Abstract:
The present invention provides methods for producing and/or expanding tumor-infiltrating lymphocytes (TILs) that can be used in adoptive immunotherapy in cancer treatment.
Public/Granted literature
- US20170349880A1 ADOPTIVE IMMUNOTHERAPY FOR TREATING CANCER Public/Granted day:2017-12-07
Information query
